Of the originally enrolled 150 infants ( 300 eyes ) in the BEAT-ROP clinical trial , 13 infants ( 26 eyes ) died ( 6 received intravitreal bevacizumab ; 7 received laser ) and 19 eyes had intraocular surgery ( 6 infants bilaterally ) .